 iHerb | $ 23.39 | |
 Pure Formulas | $ 23.39 | |
 Vitacost | $ 23.39 | |
 Amazon | $ 22.99 |
Ginkgo and horse chestnut emphasize circulation, while phosphatidylserine, an L-Dopa source, and huperzine A target cognition. None provides a strong, direct foundation for retinal or visual function, and the ginkgo amount is only maintenance-level.
Huperzine A is clearly stated but sits below the preferred cognitive range. The DopaBean and phosphatidylserine entries repeat compound and marker amounts in ways that make their true active contributions hard to interpret.
A single capsule is convenient and the cost is reasonable for the number of actives. Vision-focused buyers would be better served by a formula built around clearly dosed eye nutrients rather than this broad nootropic blend.
Several forms are named, but ginkgo marker percentages and other extract standards are missing. Ginkgo, phosphatidylserine, and huperzine are below stronger targeted amounts, and the broad stack has cognitive logic, but it is weakly aligned with dedicated vision support.
.Every listed active has a specific amount and no proprietary blend obscures the formula. Complete intake directions and inactive ingredients are not supplied, leaving part of the label unverified.
.The supplied aggregate satisfaction level is positive but trails stronger peers. The moderate feedback volume offers a useful, though not definitive, aggregate.
.The cost is not well supported by the low amounts of several key actives. Each serving offers limited effective depth for the cost, and tighter and better-standardized cognitive formulas are likely to compare more favorably.
.| Ingredient | Amount per serving |
|---|---|
Cat's Claw | 350 mg |
Horse Chestnut seed extract (Aescin) | 140 mg |
Ginkgo leaf extract (Ginkgo Flavoglycosides, Terpene Lactones) | 60 mg |
DopaBean bean extract (Catecholamines, L-Dopa) | 20 mg |
Phosphatidylserine concentrate (Lecithin, Soy) | 10 mg |
Huperzine A (Chinese Moss) | 10 mcg |
The huperzine A amount is too low for the collection's intended cognitive-support range. Capsule delivery and exact dose disclosure are useful, but the source lacks species-level standardization and the label gives no cycling guidance. Because huperzine A inhibits acetylcholinesterase, combining it with donepezil or rivastigmine may compound nausea, dizziness, or slow heart rate.
The ginkgo extract amount is a maintenance dose, while its active-marker percentages and purity standard are not disclosed. The multi-ingredient formula offers relevant cognitive cofactors but costs more per equivalent clinical ginkgo dose. Huperzine A may add cholinergic effects with acetylcholinesterase inhibitors, and the L-Dopa source may interact with dopaminergic medicines.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
